860569P

C17 Glucosyl(β) Ceramide (d18:1/17:0)

Avanti Research^™ - A Croda Brand 860569P, powder

• Synonym(e): D-glucosyl-β-1,1′-N-heptadecanoyl-D-erythro-sphingosine
• Empirische Formel (Hill-System): C₄₁H₇₉NO₈
• CAS-Nummer: 1252807-00-3
• Molekulargewicht: 714.07
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 25 mg (860569P-25mg); pkg of 1 × 5 mg (860569P-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 860569P
• Lipid-Typ: sphingolipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O

Beschreibung

Allgemeine Beschreibung

Glucosyl(β) Ceramide (β-GlcCer) is a naturally occurring glycolipid. It is also a ubiquitous intracellular metabolite.

Biochem./physiol. Wirkung

Glucosyl(β) Ceramide (β-GlcCer) regulates the activity of natural killer T (NKT) lymphocytes and displays antimetastatic effects. It is an endogenous macrophage inducible C-type lectin (Mincle) ligand, which exhibits immunostimulatory property. β-GlcCer promotes inflammatory and acquired immune responses on myeloid cells via Mincle. It acts as a potential biomarker for Gaucher′s disease.

Verpackung

5 mL Amber Glass Screw Cap Vial (860569P-25mg)

5 mL Amber Glass Screw Cap Vial (860569P-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids